NewGenIvf (NIVFW) EBITDA (2024 - 2025)
NewGenIvf (NIVFW) posted quarterly EBITDA of -$7.6 million for Q4 2025, down 20180.52% YoY from N/an in Q4 2024, and down 146.19% sequentially from $16.4 million in Q3 2025.
NewGenIvf (NIVFW) EBITDA (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed EBITDA across 2 years of filings, most recently posting -$7.6 million for Q4 2025.
- In Q4 2025, EBITDA fell 20180.52% year-over-year to -$7.6 million; the TTM figure through Dec 2025 stood at $8.6 million (changed N/A YoY), while the FY2025 annual figure was $9.5 million, up 2252.71% from the prior year.
- EBITDA fell to -$7.6 million in Q4 2025, from $16.4 million in the prior quarter.
- Over the last five years, EBITDA for NIVFW reached as high as $16.4 million in Q3 2025 and fell as low as -$7.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | -566.00 Mn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 98.88 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 1.30 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 481.89 Mn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 59.70 Mn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 124.85 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 502.86 Mn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 120.04 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -34.14 Mn |
| 10 | NewGenIvf | - | - | 524,025.00 | -7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.57 Mn |
| Sep 30, 2025 | 16.39 Mn |
| Dec 31, 2024 | -37,328.00 |
| Sep 30, 2024 | -208,254.00 |